Loading data
NCTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 25.14 m USD | 25.53 m USD | 32.45 m USD |
| Cost of revenue | 17.3 m USD | 18.18 m USD | 18.07 m USD |
| Gross profit | 7.84 m USD | 7.35 m USD | 14.38 m USD |
| Research and development expense | 621.02 k USD | 601 k USD | — |
| Operating profit | 4.9 m USD | 5.08 m USD | 13.5 m USD |
| Profit before tax | 3.1 m USD | 3.14 m USD | 10.89 m USD |
| Net income (reported basis) | 3.1 m USD | 3.14 m USD | 10.87 m USD |
| Basic earnings per share | 0.1 USD/share | 0.1 USD/share | 0.4 USD/share |
| Diluted earnings per share | 0.1 USD/share | 0.1 USD/share | 0.4 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.